OncBioMune Pharmaceuticals competitorsClear all

OncBioMune Pharmaceuticals's top competitors include Northwest Biotherapeutics, Merrimack Pharmaceuticals, CytomX Therapeutics and AVEO Pharmaceuticals.
OncBioMune Pharmaceuticals
OncBioMune Pharmaceuticals
OncBioMune specializes in innovative cancer research.
Northwest Biotherapeutics
Northwest Biotherapeutics
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
CytomX Therapeutics
CytomX Therapeutics
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
AVEO Pharmaceuticals
AVEO Pharmaceuticals
AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.
Founding Date
Founding Date
2005
Founding Date
1998
Founding Date
2000
Founding Date
2008
Founding Date
2001
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Baton Rouge, US HQ
Locations
Bethesda, US HQ
Locations
Cambridge, US HQ
Locations
South San Francisco, US HQ
Locations
Cambridge, US HQ
Boston, US
Employees
Employees
3
Employees
1721% increase
Employees
2763% decrease
Employees
15815% increase
Employees
1912% increase
Valuation ($)
Valuation ($)
209.7 k
Valuation ($)
914.4 m
Valuation ($)
51 m
Valuation ($)
341.1 m
Valuation ($)
157.3 m
Twitter followers
Twitter followers
2.5 k
Twitter followers
2.2 k
Twitter followers
1.1 k
Twitter followers
867
Twitter followers
898
Alexa Website Rank
Alexa Website Rank
321276
Alexa Website Rank
336563
Alexa Website Rank
388656
Alexa Website Rank
334342
Alexa Website Rank
N/A
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3
Employee Rating
3.5
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$2.4m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
$57.5m (FY, 2019)
Revenue (est.)
$28.8m (FY, 2019)
Net income
Net income
($9.4m) (FY, 2019)
Net income
($20.3m) (FY, 2019)
Net income
($17.3m) (FY, 2019)
Net income
($102.2m) (FY, 2019)
Net income
$9.4m (FY, 2019)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 135.9m
Total funding raised
$ 79.4m
Total funding raised
$ 132.4m
Total funding raised
$ 224m
For sources of this data, please see the company profile

View company profiles

Northwest Biotherapeutics
HQ
Bethesda, US
Employees
17↑ 21% increase

Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.

View company
Merrimack Pharmaceuticals
HQ
Cambridge, US
Employees
27

Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.

View company
CytomX Therapeutics
HQ
South San Francisco, US
Employees
158↑ 15% increase

CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.

View company
AVEO Pharmaceuticals
HQ
Cambridge, US
Employees
19↑ 12% increase

AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.

View company